Biopharma tech strategies in an era defined by data and AI
Malay Gandhi, Head of Strategy at Benchling, will discuss hurdles that biopharma needs to overcome to deploy a solid tech strategy as well as the key technologies that companies are investing in.
The discussion will be grounded by evidence and insights from the recent Biopharma Technology Benchmark Report, a survey of 300 global biopharma R&D and IT executives.
Thank you for registering. We'll email you a calendar invite along with the details.